Cervical HPV infection
Conditions
Interventions
High risk HPV infected:Study group (drug) and control group (natural)
High risk HPV infected+ LSIL:Study group (drug) and control group (natural)
Sponsors
The Second Affiliated Hospital of Xi'an Jiaotong University
Eligibility
Sex/Gender
Female
Age
25 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1) The patients were tested positive by HPV; 2) Women aged 25-65, married or having sex history; 3) Patients without immune system and major systemic diseases; 4) The menstrual cycle is not less than 25 days; 5) Those who can insist on completing the treatment and follow up on schedule; 6) No other treatment was used during the treatment; 7) The treatment plan was randomly divided into two groups and the patients were told to follow up; 8) Women of childbearing age agreed to take reliable contraceptive measures during the study and within 6 months after the completion or termination of the trial.
Exclusion criteria
Exclusion criteria: 1) Patients with acute genital inflammation; 2) Patients with cognitive dysfunction; 3) Malignant tumors were excluded; 4) Positive pregnancy test was found during pregnancy, lactation, 3 months after delivery and before administration; 5) Patients with liver and kidney dysfunction; 6) Allergic to the drugs used in this study; 7) Have a history of serious drug abuse or alcohol abuse.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cervical HPV detection; | — |
Countries
China
Contacts
Public ContactXie Xiuying
The Second Affiliated Hospital of Xi'an Jiaotong University
Outcome results
None listed